ROSSARI vs SHK: Stock Comparison
ROSSARI BIOTECH is the larger company by market capitalisation. ROSSARI BIOTECH shows a lower P/E, a higher ROE and faster revenue growth, while S H KELKAR AND CO. shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ROSSARI leads 11; SHK leads 2 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ROSSARI | SHK |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | ROSSARI | SHK |
|---|---|---|
| Live Price | ₹446.15 | ₹141.22 |
| Day Change | -0.75% | -1.64% |
| Volume | 36,449 | 2.31 L |
| 52-Week High | ₹690.3 | ₹257.44 |
| 52-Week Low | ₹375 | ₹111.98 |
| Distance from 52W High | -35.37% | -45.14% |
Valuation
| Metric | ROSSARI | SHK |
|---|---|---|
| Market Cap | ₹2,491 Cr | ₹1,952 Cr |
| P/E Ratio | 16.53x | 22.24x |
| P/B Ratio | 1.87x | 1.46x |
| EPS | ₹6.34 | ₹1.1 |
| Book Value | ₹240.71 | ₹98.43 |
| Dividend Yield | 0.11% | 0.71% |
Growth
| Metric | ROSSARI | SHK |
|---|---|---|
| Revenue Growth (TTM YoY) | 18.2% | 13.8% |
| EPS Growth (TTM YoY) | 33.5% | -98.2% |
| Qtr Sales Growth | 44.56% | -49.12% |
| Qtr Profit Growth | 2.42% | -66.52% |
Profitability & Leverage
| Metric | ROSSARI | SHK |
|---|---|---|
| ROE | 11.19% | 5.08% |
| ROCE | 10.1% | 0.49% |
| Net Margin | 6.14% | 2.94% |
| Operating Margin | 9.56% | 7.09% |
| Debt to Equity | 0.31x | 0.62x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ROSSARI | SHK |
|---|---|---|
| Promoter Holding | 63.63%▼ 0.01 pp | 43.4% |
| FII Holding | 2.02%▼ 0.16 pp | 5.92%▼ 1.5 pp |
| DII Holding | 14.64%▼ 3.56 pp | 6.01%▲ 0.83 pp |
| Public Holding | 15.2%▲ 3.74 pp | 33.21%▲ 0.68 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ROSSARI BIOTECH and S H KELKAR AND CO..
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.